Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

pSTAT3 in luminal breast cancer - results from BIG-2-98 trial

Dr Amir Sonnenblick - Hebrew University Medical Center, Jerusalem, Israel
pSTAT3 in luminal breast cancer - results from BIG-2-98 trial ( Dr Amir Sonnenblick - Hebrew University Medical Center, Jerusalem, Israel )
12 May 2017

Adaptive trial design on breast cancer

Prof Laura Vant Veer - University of California San Francisco, San Francisco, USA
Adaptive trial design on breast cancer ( Prof Laura Vant Veer - University of California San Francisco, San Francisco, USA )
11 May 2017

The molecular characterisation of oesophageal adenocarcinoma

Prof Rebecca Fitzgerald - University of Cambridge, Cambridge, UK
The molecular characterisation of oesophageal adenocarcinoma ( Prof Rebecca Fitzgerald - University of Cambridge, Cambridge, UK )
27 Apr 2017

Discovering genes in mammary cancer by insertional mutagenesis

Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands
Discovering genes in mammary cancer by insertional mutagenesis ( Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands )
27 Apr 2017

Hallmarks of cancer cell development

Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland
Hallmarks of cancer cell development ( Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland )
27 Apr 2017

Pembrolizumab and indoximod for melanoma

Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA
Pembrolizumab and indoximod for melanoma ( Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA )
13 Apr 2017

Nivolumab for NSCLC: five years on

Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Nivolumab for NSCLC: five years on ( Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
12 Apr 2017

Long-term clinical outcomes and analyses of atezolizumab for mTNBC

Prof Peter Schmid - Barts Cancer Institute, London, UK
Long-term clinical outcomes and analyses of atezolizumab for mTNBC ( Prof Peter Schmid - Barts Cancer Institute, London, UK )
12 Apr 2017

Final overall survival analysis of MONARCH 1

Dr Hope Rugo - UCSF Medical Center, San Francisco, USA
Final overall survival analysis of MONARCH 1 ( Dr Hope Rugo - UCSF Medical Center, San Francisco, USA )
11 Apr 2017

Redefining tamoxifen for breast cancer

Gokul Das - Roswell Park Cancer Institute, Buffalo, USA
Redefining tamoxifen for breast cancer ( Gokul Das - Roswell Park Cancer Institute, Buffalo, USA )
11 Apr 2017

Treatment choices for HER2 amplified colorectal cancer

Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy
Treatment choices for HER2 amplified colorectal cancer ( Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy )
10 Apr 2017

Final results of the HERACLES trial in HER2-amplified colorectal cancer

Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy
Final results of the HERACLES trial in HER2-amplified colorectal cancer ( Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy )
10 Apr 2017